Shortly after COVID-19 entered our collective lexicon, investments began pouring into the health care industry.
The warts on the U.S. health care system that COVID-19 exposed were enough for lenders, backers and buyers to continue to throw money at the companies – or even ideas – that could cover up or eradicate those warts.
Sign up for HHCN + to read this exclusive content.
